Mitral valve

ACC 2023 | TRILUMINATE Pivotal: Edge-to-Edge Treatment in Patients with Tricuspid Regurgitation

Tricuspid regurgitation is a common and impairing disease. Optimal medical therapy (OMT) is limited, valve surgery is...

ACC 2023 | COAPT Study: 5 Year Followup after Transcatheter Repair of Secondary Mitral Regurgitation

The five year outcomes of the multicenter open label COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous...

Secondary Mitral Regurgitation: Stages of Heart Failure and Prognostic Implications after Transcatheter Edge-to-Edge Repair

We are already familiar with the strong impact of secondary mitral valve regurgitation (SMR) in survival and...

Edge-to-Edge Repair Reduces Hospitalization and Mortality Rates in Secondary Mitral Valve Regurgitation?

Severe secondary mitral valve regurgitation is associated to hospitalization and mortality.  The COAPT study has shown the superiority...

A Simple Score for Mortality and Cardiac Failure after Edge-to-Edge with MitraClip

Mitral regurgitation (MR) is the most frequent type of valve heart disease, and the COAPT has shown...

TCT 2022 | Edge-to-Edge Repair in Patients with Severe Mitral Insufficiency and Cardiogenic Shock: Analysis of the TVT Registry

Approximately 1 in 5 patients admitted for cardiogenic shock (CS) were observed to have moderate to severe...

SOLACI-SOCIME 2022 | Transcatheter treatment of mitral valve regurgitation, by Dr. Luis Nombela Franco

Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress. In this case, consult...

SOLACI-SOCIME 2022 | When is indicated the transcatheter treatment of mitral regurgitation

Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress. In this case, consult...